Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 1, 1997, Pages 45-51

  Purohit, A ^a   Froome, V A ^a   Wang, D Y ^a   Potter, B V L ^b   Reed, M J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE 3 SULFAMATE DERIVATIVE; PRASTERONE; PRASTERONE SULFATE; STERYL SULFATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; LIVER; MALE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; RAT; SPLEEN; TISSUE SPECIFICITY;

ANIMALS; CARBON RADIOISOTOPES; ENZYME INHIBITORS; ESTRONE; FEMALE; HUMANS; KINETICS; LEUKOCYTES; LIVER; MALE; METABOLIC CLEARANCE RATE; RATS; REPRODUCIBILITY OF RESULTS; SCINTILLATION COUNTING; SPLEEN; SULFATASES; TISSUE DISTRIBUTION; TRITIUM;

EID: 0030833929     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00018-6     Document Type: Article

References (34)

1. Pasqualini J. R., Gelly C., Nguyen B.-L. and Vella C.: Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34 (1989) 155-163.
2. Pasqualini J. R., Schatz B., Varin C. and Nguyen B.-L.: Recent data on estrogen sulfatase and sulfotransferases activities in human breast cancer. J. Steroid Biochem. Molec. Biol. 41 (1992) 323-329.
3. Pasqualini J. R., Chetrite G., Nguyen B.-L., Maloche C., Delalonde L., Talbi M., Feinstein M.-C., Blacker C., Botella J. and Paris J.: Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J. Steroid Biochem. Molec. Biol. 53 (1995) 407-412.
4. Santner S. J., Feil P. D. and Santen R. J.: In situ estrogen production via estrone sulfatase pathway in breast tumors: relative importance versus aromatase pathway. J. Clin. Endocr. Metab. 59 (1984) 29-33.
5. Noel C. T., Reed M. J., Jacobs H. S. and James V. H. T.: The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem. 14(1981) 1101-1105.
6. Pasqualini J. R., Chetrite G., Blacker C., Feinstein M.-C., Delalonde L., Talbi M. and Maloche C.: Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocr. Metab. 81 (1996) 1460-1464.
7. James V. H. T., McNeill J. M., Lai L. C., Newton C. J., Ghilchik M. W. and Reed M. J.: Aromatase activity in normal breast and breast tumor tissue: in vivo and in vitro studies. Steroids 50 (1987) 269-279.
8. Reed M. J. and Purohit A.: Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev. Endocr.-Relat. Cancer 45 (1993) 51-62.
9. Reed M. J., Purohit A., Howarth N. M. and Potter B. V. L.: Steroid sulphatase inhibitors: a new endocrine therapy. Drugs of the Future 19 (1994) 673-680.
10. Santner S. J., Levin M. C. and Santen R. J.: Estrone sulfate stimulates growth of nitrosomethylurea induced breast carcinoma in vivo in the rat. Int. J. Cancer 46 (1990) 73-78.
11. Masamura S., Santner S. J. and Santen R. J.: Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase. J. Steroid Biochem. Molec. Biol. 58 (1996) 425-430.
12. Poortman, J., Andriesse, R., Agema, A., Donker, G. H., Schwarz, F. and Thijssen, J. H. H., Adrenal androgen secretion and metabolism in postmenopausal women. In Adrenal Androgens, eds A. R. Genazzani, J. H. H. Thijssen and P. K. Siiteri. Raven Press, New York, 1980, pp. 219-240.
13. Purohit A., Dauvois S., Parker M. G., Potter B. V. L., Williams G. J. and Reed M. J.: The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. J. Steroid Biochem. Molec. Biol. 50 (1995) 101-104.
14. Carlstrom K., Doberl A., Gershagen S. and Rannevik G.: Peripheral plasma levels of DHA-S and DHA, androstenedione and testosterone following different doses of danazol. Acta Obstet. Gynecol Scand. 123 (Suppl.) (1984) 125-129.
15. Santner S. J. and Santen R. J.: Inhibition of estrone sulfatase and 17β-hydroxysteroid dehydrogenase by anti-estrogens. J. Steroid Biochem. Molec. Biol. 45 (1993) 383-390.
16. Pasqualini J. R., Maloche C., Maroni M. and Chetrite G.: Effect of progestogen promegestone (R-5020) on mRNA of the oestrone sulphatase in MCF-7 human mammary cancer cells. Anticancer Res. 14 (1994) 1589-1594.
17. Birnbock H. and Von Angerer E.: Sulphate derivatives of 2-phenylindoles as novel steroid sulphatase inhibitors. Biochem. Pharmacol. 39 (1990) 1709-1713.
18. Duncan L. J., Purohit A., Howarth N. M., Potter B. V. L. and Reed M. J.: Inhibition of estrone sulfatase activity by estrone-3-O-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 53 (1993) 293-303.
19. Li P.-K., Young B. L., Bender W. H., Martino D. M. and Liu F. T.: Synthesis and biochemical studies of estrone sulfatase inhibitors. Steroids 58 (1993) 106-111.
20. Howarth N. M., Purohit A., Reed M. J. and Potter B. V. L.: Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37 (1994) 219-221.
21. Purohit A., Williams G. J., Howarth N. M., Potter B. V. L. and Reed M. J.: Inactivation of steroid sulfatase by an active site-directed inhibitor: estrone-3-O-sulfamate. Biochemistry 34 (1995) 11508-11514.
22. Purohit A., Williams G. J., Roberts C. J., Potter B. V. L. and Reed M. J.: In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int. J. Cancer 62 (1995) 106-111.
23. Reed M. J., Lai L. C., Owen A. M., Singh A., Coldham N. G., Purohit A., Ghilchik M. W., Shaikh N. A. and James V. H. T.: Effects of treatment with 4-hydroxyandrostendione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer Res. 50 (1990) 193-196.
24. Dowsett M., Cunningham D. C., Stein R. C., Evans S., Dehennin L., Hedley A. and Coombes R. C.: Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. Cancer Res. 49 (1989) 1306-1311.
25. Hirato K., Suzuki T., Hondo T., Saito H. and Yanaihara T.: Steroid sulfatase activities in human leucocytes: biochemical and clinical aspects. Endocr. Japon. 38 (1991) 597-602.
26. Soliman H. R., Dire D., Boudou P., Julien R., Launay J.-M., Brerault J.-L., Villette J.-M. and Fiet J.: Characterization of estrone sulfatase activity in human thrombocytes. J. Steroid Biochem. Molec. Biol. 46 (1993) 215-226.
27. Han H.-D., Fencl M. de M. and Tulchinsky D.: Variations in estrone sulfatase activity in human leucocytes. J. Clin. Endocr. Metab. 65 (1987) 1026-1030.
28. Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72 (1976) 248-254.
29. Sahm U. G., Williams G. J., Purohit A., Hidalgo Aragones M. I., Parish D., Reed M. J., Potter B. V. L. and Pouton C. W.: Development of an oral formulation for oestrone 3-O-sulphamate, a potent sulphatase inhibitor. Pharmaceut. Sci. 2 (1996) 17-20.
30. Lowis E. I. and Oakey R. E.: Steroid sulphatase deficiency: identification of heterozygotes using hydrolysis of dehydroepiandrosterone sulphate by peripheral leucocytes. Ann. Clin. Biochem. 33 (1996) 219-226.
31. Hidalgo Aragones M. I., Purohit A., Parish D., Sahm U. G., Pouton C. W., Potter B. V. L. and Reed M. J.: Pharmacokinetics of oestrone-3-O-sulphamate. J. Steroid Biochem. Molec. Biol. 58 (1996) 611-617.
32. Poulin R. and Labrie F.: Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in ZR-75-1 human breast cancer cell line. Cancer Res. 46 (1986) 4933-4937.
33. Dauvois S. and Labrie F.: Androstenedione and androst-5-ene 3β,17β-diol stimulate DMBA-induced mammary tumors - role of aromatase. Breast Cancer Res. Treat. 13 (1989) 61-69.
34. Purohit A., Woo L. W. L., Singh A., Winterbom C. J., Potter B. V. L. and Reed M. J.: In vivo activity of 4-methylcoumarin-7-O-sulfamate, a non-steroidal, non-estrogenic steroid sulfatase inhibitor. Cancer Res. 56 (1996) 4950-4955.